SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-22-069454
Filing Date
2022-11-04
Accepted
2022-11-04 17:03:13
Documents
9
Period of Report
2022-11-04

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea168100-pre14a_180lifesci.htm PRE 14A 284615
2 GRAPHIC image_001.jpg GRAPHIC 3638
3 GRAPHIC image_002.jpg GRAPHIC 1102
4 GRAPHIC image_003.jpg GRAPHIC 1791
5 GRAPHIC image_004.jpg GRAPHIC 4102
6 GRAPHIC image_005.jpg GRAPHIC 821
7 GRAPHIC image_006.jpg GRAPHIC 659
8 GRAPHIC image_007.jpg GRAPHIC 610
9 GRAPHIC image_008.jpg GRAPHIC 1151
  Complete submission text file 0001213900-22-069454.txt   305979
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38105 | Film No.: 221363000
SIC: 2834 Pharmaceutical Preparations